Finance
Weight Loss Drug Trial Shows 21% Weight Loss
Novo Nordisk's Wegovy drug showed patients lost an average of 21% body weight over 72 weeks in a recent trial. The drug also offers proven cardiovascular benefits, making it a strong contender in the booming weight loss market. Competition remains fierce, with Eli Lilly also making significant gains.